Table 2.
Clinical characteristics of the newborns included in measurements of macrophage migration inhibitory factor and d-dopachrome tautomerase concentrations in umbilical cord blood.
| Preterm newborns (n = 34) | Term newborns (n = 60) | |
|---|---|---|
| Maternal group B streptococcal status, n (%) | ||
| Positive | 3 (9) | 6 (10) |
| Negative | 25 (74) | 39 (65) |
| Unknown | 6 (18) | 15 (25) |
| Intrapartum antibiotic prophylaxis, n (%) | 7 (21) | 6 (10) |
| Antenatal steroids, n (%) | 31 (91) | 3 (5) |
| Mode of delivery, n (%) | ||
| Vaginal | 6 (18) | 30 (50) |
| Emergency cesarean section | 16 (47) | 3 (5) |
| Elective cesarean section | 12 (35) | 27 (45) |
| Male gender, n (%) | 22 (65) | 26 (43) |
| Median gestational age at birth, weeks [interquartile range (IQR)] | 34 (32–36) | 39 (39–40) |
| Median birthweight, g (IQR) | 1,960 (1,665–2,295) | 3,440 (3,280–3,670) |
| Median umbilical artery pH (IQR) | 7.30 (7.26–7.33) | 7.27 (7.21–7.30) |
| Median umbilical vein pH (IQR) | 7.35 (7.31–7.37) | 7.33 (7.29–7.37) |
| Median 1 min Apgar score (IQR) | 9 (7–9) | 9 (9–9) |
| Median 5 min Apgar score (IQR) | 9 (8–9) | 10 (9–10) |
| Median 10 min Apgar score (IQR) | 10 (9–10) | 10 (10–10) |